Quest Diagnostics Inc. (NYSE: DGX) last traded at $230.97, up 0.07% on the session. The quote above updates while this page is open; the figures below are drawn from Quest Diagnostics Inc.’s own filings and are restated only when a new one is published.
Quest Diagnostics Inc. trades on NYSE under the ticker DGX. Its market capitalisation is $25.49 billion.
Valuation measures for Quest Diagnostics Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $25.49B |
|---|---|
| Enterprise value | $33.99B |
| P/E ratio | 24.52 |
| Price / sales | 2.21 |
| Price / book | 3.39 |
| Beta | -0.11 |
Trailing-twelve-month figures tagged in Quest Diagnostics Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $11.56B |
|---|---|
| Net income (TTM) | $1.06B |
| EPS (TTM) | $9.42 |
| Gross margin | 33.11% |
| Operating margin | 14.10% |
| Return on equity | 14.13% |
| Cash | $626.00M |
Range and volume for DGX over the past 52 weeks.
| 52-week high | $248.84 |
|---|---|
| 52-week low | $171.18 |
| Volume | 775.4K |
| Average volume | 1.04M |
| Previous close | $230.81 |
Dividend history for Quest Diagnostics Inc. over the trailing twelve months.
| Dividend yield | 1.44% |
|---|---|
| Dividend per share (TTM) | $3.32 |
| Payout ratio | 35.24% |
Invest a chosen dollar amount in Quest Diagnostics Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell DGX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.